Featured

News

New report reveals challenges, opportunities in life science R&D experiments

Synthace releases comprehensive analyst report: Lab automation & experimentation in life science R&D 2023-2024, highlighting challenges faced in R&D.

Will Patrick

 4 min

News

Great place to work honors Synthace as a top tech workplace in the UK

Synthace, a digital experiment platform for life science R&D, has been recognized as one of the best workplaces in UK tech by Great Place to Work UK.

Will Patrick

 3 min

News

Synthace, a digital experiment platform for life science R&D, records strongest year yet

Synthace, a digital life science experiment platform, announces its most successful year on record with major adoption, expansion, and industry recognition

Will Patrick

 8 min

News

Synthace is officially one of the UK’s Best Workplaces™ for Wellbeing

Synthace has officially been named one of the UK’s Best Workplaces™ for Wellbeing (2023) by Great Place to Work®, the authority on workplace culture.

Will Patrick

 4 min

News

Impact Fifty: Synthace wins coveted award recognizing positive impact

Synthace has this week won a coveted international award recognizing the world's 50 most impactful companies to work for.

Will Patrick

 4 min

News

Synthace a finalist in the 2022-2023 Cloud Awards

International Cloud Computing Awards program announces finalists, with Synthace up for Cloud Disruptor of the Year 2022-2023.

Will Patrick

 4 min

News

Synthace shortlisted for 2022-2023 Cloud Awards

International Cloud Computing Awards program announces initial shortlist, with Synthace up for Cloud Disruptor of the Year 2022-2023.

Will Patrick

 5 min

News

Synthace wins BioTech Breakthrough Overall BioTech Solution award

We're proud to announce we're the winners of Biotech Breakthrough's Overall BioTech Solution of the Year, recognizing the change we're driving in biotech.

Will Patrick

 4 min

News

Synthace appoints Dr. Donald Deieso as new board chair

Dr. Deieso joins at a time of strong momentum: Series C raised in the last year, a doubling of ARR, and expansion to 8 of the world’s top pharma companies.

Will Patrick

 4 min